Login
World Cup
Military
Social Media
Motorsports
Protestors
Parade
Benjamin Netanyahu
Soccer
Donald Trump
Artificial Intelligence
Israel-Hamas Conflict
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

FDA clears CAP-003 Parkinson’s gene therapy to be tested in trials

Summary by Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Parkinson's News TodayParkinson's News Today

FDA clears CAP-003 Parkinson’s gene therapy to be tested in trials

The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Parkinson's News Today broke the news in on Thursday, June 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Maryland

Maryland

News
For You
SearchBlindspotLocal